POINT OF CARE TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-144423 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Point of Care Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL POINT OF CARE TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT OF CARE TESTING MARKET
7.1 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL POINT OF CARE TESTING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Abaxis, Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Abbott
16.3 Acubiotech Co. Ltd
16.4 Acon Laboratories
16.5 Becton, Dickinson and Company
16.6 Biolytical Laboratories
16.7 BioMrieux SA
16.8 Bio-Rad Laboratories
16.9 Danaher Corporation (HemoCue)
16.10 Dexcom Inc
16.11 Dragerwerk Ag & Co.
16.12 LifeScan IP Holdings, LLC
16.13 Medtronic
16.14 Meridian Bioscience Inc
16.15 Nova Biomedical
16.16 OraSure Technologies Inc.
16.17 F. Hoffmann-La Roche Ltd
16.18 Siemens Healthineers
16.19 Sysmex Corporation
16.20 Trinity Biotech
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By ProductGlucose Monitoring
 o Strips
 o Meters
 o Lancets
Cardiometabolic Testing Products
 o Cardiac Marker Testing
    o High-sensitivity Troponin I (Hstnl)
    o Brain Natriuretic Peptide (Bnp)
    o D-dimer
    o Creatine Kinase-mb (Ck-mb)
    o Myoglobin
    o Others
 o Blood Gas/electrolyte Testing Products
 o HBA1C Testing
Infectious Disease Testing Products
 o Influenza Testing Products
 o HIV Testing Products
 o Hepatitis C Testing Products
 o Sexually Transmitted Disease (Std) Testing Products
 o Healthcare-associated Infection (Hai) Testing Products
 o Respiratory Infection Testing Products
 o Tropical Disease Testing Products
 o Others
Coagulation Testing Products
 o PT/INR Testing Products
 o Activated clotting Time (ACT/APTT) Testing Products
Pregnancy And Fertility Testing Products
 o Pregnancy Testing Products
 o Fertility Testing Products
Tumor/cancer Marker Testing Products
Urinalysis Testing Products
Cholesterol Testing Products
Hematology Testing Products
Drug-of-abuse (Doa) Testing Products
Fecal Occult Testing Products
Others
By Technology
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays
Agglutination Assays
Flow-through
Solid Phase
Biosensors
By Prescription
OTC Testing
Prescription Testing
By Application
Cardio Metabolic Testing
Infectious Disease Testing
Nephrology Testing
Drug-of-abuse (Doa) Testing
Blood Glucose Testing
Pregnancy Testing
Cancer Biomarker Testing
Others
By End-user
Hospitals
Diagnostic Centers
Research Laboratories
Home-care Settings
Others
Companies
Abaxis, Inc
Abbott
Acubiotech Co. Ltd
Acon Laboratories
Becton, Dickinson and Company
Biolytical Laboratories
BioMrieux SA
Bio-Rad Laboratories
Danaher Corporation (HemoCue)
Dexcom Inc
Dragerwerk Ag & Co.
LifeScan IP Holdings, LLC
Medtronic
Meridian Bioscience Inc
Nova Biomedical
OraSure Technologies Inc.
F. Hoffmann-La Roche Ltd
Siemens Healthineers
Sysmex Corporation
Trinity Biotech
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.